Cheng‐Han Lee

4.8k total citations
81 papers, 3.2k citations indexed

About

Cheng‐Han Lee is a scholar working on Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Cheng‐Han Lee has authored 81 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 35 papers in Obstetrics and Gynecology and 27 papers in Molecular Biology. Recurrent topics in Cheng‐Han Lee's work include Sarcoma Diagnosis and Treatment (38 papers), Uterine Myomas and Treatments (30 papers) and Endometrial and Cervical Cancer Treatments (26 papers). Cheng‐Han Lee is often cited by papers focused on Sarcoma Diagnosis and Treatment (38 papers), Uterine Myomas and Treatments (30 papers) and Endometrial and Cervical Cancer Treatments (26 papers). Cheng‐Han Lee collaborates with scholars based in Canada, United States and Australia. Cheng‐Han Lee's co-authors include Cornelis van Breemen, Damon Poburko, Kuo‐Hsing Kuo, Íñigo Espinosa, Lien Hoang, Sarah Chiang, Jiazhen Dai, Marisa R. Nucci, C. Blake Gilks and Matt van de Rijn and has published in prestigious journals such as Circulation Research, The Journal of Physiology and Cancer Research.

In The Last Decade

Cheng‐Han Lee

81 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Han Lee Canada 36 1.3k 1.1k 966 569 457 81 3.2k
Shih‐Chieh Lin Taiwan 28 352 0.3× 1.2k 1.1× 307 0.3× 395 0.7× 278 0.6× 77 2.6k
Jan Oosting Netherlands 32 468 0.4× 1.1k 0.9× 99 0.1× 141 0.2× 767 1.7× 73 2.5k
Helen Papadaki Greece 23 222 0.2× 708 0.6× 224 0.2× 176 0.3× 411 0.9× 78 1.9k
Agnès Ribeiro France 27 339 0.3× 1.3k 1.2× 127 0.1× 87 0.2× 704 1.5× 49 2.7k
Helmut Bonkhoff Germany 35 2.5k 1.9× 1.6k 1.4× 42 0.0× 118 0.2× 768 1.7× 79 4.4k
Steven E. Scherer United States 19 326 0.3× 906 0.8× 83 0.1× 81 0.1× 247 0.5× 37 1.9k
Pascal Roger France 33 175 0.1× 893 0.8× 86 0.1× 146 0.3× 767 1.7× 93 2.8k
Ying Xiong China 22 331 0.3× 529 0.5× 135 0.1× 142 0.2× 409 0.9× 92 1.5k
Arjen R. Mensenkamp Netherlands 27 281 0.2× 875 0.8× 52 0.1× 57 0.1× 488 1.1× 67 2.2k
Paul D. Upton United Kingdom 38 3.3k 2.5× 1.8k 1.6× 62 0.1× 31 0.1× 423 0.9× 76 5.2k

Countries citing papers authored by Cheng‐Han Lee

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Han Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Han Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Han Lee more than expected).

Fields of papers citing papers by Cheng‐Han Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Han Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Han Lee. The network helps show where Cheng‐Han Lee may publish in the future.

Co-authorship network of co-authors of Cheng‐Han Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Han Lee. A scholar is included among the top collaborators of Cheng‐Han Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Han Lee. Cheng‐Han Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Laura, Krista M. Vincent, Zhihua Xu, et al.. (2024). Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer. Oncogene. 43(22). 1688–1700. 1 indexed citations
2.
Tessier‐Cloutier, Basile, F. Kommoss, David L. Kolin, et al.. (2023). Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. Modern Pathology. 37(1). 100374–100374. 10 indexed citations
3.
Kommoss, F., Brooke E. Howitt, Krisztina Hanley, et al.. (2023). High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker. Modern Pathology. 36(3). 100044–100044. 13 indexed citations
4.
Fernández, Marta Llauradó, E. Marielle Hijmans, Annemiek M.C. Gennissen, et al.. (2022). NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition. Molecular Cancer Therapeutics. 21(12). 1862–1874. 9 indexed citations
5.
Shrestha, Raunak, Marta Llauradó Fernández, Amy Dawson, et al.. (2021). Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability. Cancer Research. 81(7). 1681–1694. 26 indexed citations
6.
Kang, Eunyoung, Basile Tessier‐Cloutier, Máire A. Duggan, et al.. (2021). Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix. Histopathology. 79(2). 160–167. 13 indexed citations
7.
Boroujeni, Amir Momeni, Robert Wolber, Stephen Yip, et al.. (2020). Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Modern Pathology. 34(5). 1008–1016. 33 indexed citations
8.
Stewart, Colin J.R., Sarah Chiang, Gulisa Turashvili, et al.. (2020). p53 immunohistochemical analysis of fusion‐positive uterine sarcomas. Histopathology. 78(6). 805–813. 21 indexed citations
9.
Turashvili, Gulisa, Robert A. Soslow, Kay J. Park, et al.. (2020). High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities. Modern Pathology. 33(9). 1861–1870. 28 indexed citations
10.
Binzer-Panchal, Amrei, Mehran Ghaderi, Tjalling Bosse, et al.. (2019). Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes. Clinical Cancer Research. 25(7). 2155–2165. 14 indexed citations
11.
Wang, Gang, Diana N. Ionescu, Cheng‐Han Lee, et al.. (2019). PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer. Lung Cancer. 136. 1–5. 27 indexed citations
12.
Tessier‐Cloutier, Basile, Robert A. Soslow, Colin J.R. Stewart, Martin Köbel, & Cheng‐Han Lee. (2018). Frequent loss of claudin‐4 expression in dedifferentiated and undifferentiated endometrial carcinomas. Histopathology. 73(2). 299–305. 24 indexed citations
13.
McCluggage, W. Glenn & Cheng‐Han Lee. (2018). YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99. International Journal of Gynecological Pathology. 38(6). 528–532. 16 indexed citations
14.
Ali, Rola H., Salah Al-Waheeb, Waleed Al-Ali, et al.. (2014). Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait. Human Pathology. 45(12). 2453–2462. 7 indexed citations
15.
Edris, Badreddin, Íñigo Espinosa, Thomas Mühlenberg, et al.. (2012). ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. The Journal of Pathology. 227(2). 223–233. 66 indexed citations
16.
Dai, Jiazhen, Kuo‐Hsing Kuo, Joyce M. Leo, Cornelis van Breemen, & Cheng‐Han Lee. (2005). Rearrangement of the close contact between the mitochondria and the sarcoplasmic reticulum in airway smooth muscle. Cell Calcium. 37(4). 333–340. 45 indexed citations
17.
Lee, Cheng‐Han, Kuo‐Hsing Kuo, Jiazhen Dai, et al.. (2004). Calyculin-A disrupts subplasmalemmal junction and recurring Ca2+ waves in vascular smooth muscle. Cell Calcium. 37(1). 9–16. 23 indexed citations
18.
Poburko, Damon, Cheng‐Han Lee, & Cornelis van Breemen. (2004). Vascular smooth muscle mitochondria at the cross roads of Ca2+ regulation. Cell Calcium. 35(6). 509–521. 24 indexed citations
19.
Poburko, Damon, Kuo‐Hsing Kuo, Jiazhen Dai, Cheng‐Han Lee, & Cornelis van Breemen. (2003). Organellar junctions promote targeted Ca2+ signaling in smooth muscle: why two membranes are better than one. Trends in Pharmacological Sciences. 25(1). 8–15. 81 indexed citations
20.
Lee, Cheng‐Han, et al.. (2001). The mechanism of phenylephrine‐mediated [Ca2+]i oscillations underlying tonic contraction in the rabbit inferior vena cava. The Journal of Physiology. 534(3). 641–650. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih‐Chieh Lin Breakdown of academic impact, for papers by Jan Oosting Breakdown of academic impact, for papers by Helen Papadaki Breakdown of academic impact, for papers by Agnès Ribeiro Breakdown of academic impact, for papers by Helmut Bonkhoff Breakdown of academic impact, for papers by Steven E. Scherer Breakdown of academic impact, for papers by Pascal Roger Breakdown of academic impact, for papers by Ying Xiong Breakdown of academic impact, for papers by Arjen R. Mensenkamp Breakdown of academic impact, for papers by Paul D. Upton
Rankless by CCL
2026